Aurobindo Pharma Announces 39th AGM on August 27, 2026
Aurobindo Pharma Limited will hold its 39th Annual General Meeting (AGM) on August 27, 2026. The meeting will be conducted via video conference. Notices were published on July 30, 2026.
The announcement of the AGM date is a standard procedural event for listed companies and typically has a minimal impact on the company's stock price or business operations.
The announcement is a routine corporate event notification and does not contain any information that would positively or negatively impact the company's stock or operations.
Aurobindo Pharma Limited has announced that its 39th Annual General Meeting (AGM) will be held on Thursday, August 27, 2026, at 3:30 p.m. IST. The meeting will be conducted through Video Conferencing / Other Audio-Visual Means.
The company has published notices regarding this in the newspapers Business Standard and Nava Telangana on July 30, 2026. Shareholders are informed of the upcoming AGM through these publications. The corporate and registered office details for Aurobindo Pharma Limited are also provided.
This announcement is a routine corporate communication regarding the scheduling of the Annual General Meeting.
What to do with a filing like this
Aurobindo Pharma Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aurobindo Pharma Limited. Read the original for the full detail.